Cargando…
Current early diagnostic biomarkers of prostate cancer
Prostate cancer (PCa) has become to have the highest incidence and the second mortality rate in western countries, affecting men's health to a large extent. Although prostate-specific antigen (PSA) was discovered to help diagnose the cancer in an early stage for decades, its specificity is rela...
Autores principales: | Qu, Min, Ren, Shan-Cheng, Sun, Ying-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104079/ https://www.ncbi.nlm.nih.gov/pubmed/24830695 http://dx.doi.org/10.4103/1008-682X.129211 |
Ejemplares similares
-
Penile rehabilitation following prostate cancer treatment: review of current literature
por: Clavell-Hernandez, Jonathan, et al.
Publicado: (2015) -
Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications
por: Singh, B Harpreet, et al.
Publicado: (2014) -
Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer
por: Hegemann, Miriam, et al.
Publicado: (2019) -
Current opinion and mechanistic interpretation of combination therapy for castration-resistant prostate cancer
por: Xu, Jin, et al.
Publicado: (2019) -
MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery
por: Kumar, Binod, et al.
Publicado: (2016)